You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chelator

Showing 1 - 25 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Recurrent Epithelioid Mesothelioma, Serous Ovarian Cancer, Metastatic or Locally Advanced Pancreatic Ductal

Completed
  • Advanced Recurrent Epithelioid Mesothelioma
  • +2 more
  • Bethesda, Maryland
  • +6 more
Apr 8, 2022

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

Cancers With HER2 Expression Trial in United Kingdom, United States (BAY2701439)

Recruiting
  • Cancers With HER2 Expression
  • Baltimore, Maryland
  • +5 more
Jan 18, 2023

Parkinson's Disease Trial in London (Deferiprone 20mg, Placebo, Deferiprone 30mg)

Completed
Has Results
  • Parkinson's Disease
  • Deferiprone 20mg
  • +2 more
  • London, United Kingdom
    Centre for Neuroscience, Imperial College London
Jun 3, 2020

Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))

Completed
Has Results
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
May 30, 2021

Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)

Terminated
Has Results
  • Transfusional Iron Overload
  • Beta-Thalassemia
  • Boston, Massachusetts
  • +8 more
Jun 10, 2021

Ovarian Tumors Malignant (Excl Germ Cell), Peritoneal Carcinoma, Fallopian Tube Cancer Trial (trientine diHCl, pegylated

Completed
Has Results
  • Ovarian Neoplasms Malignant (Excl Germ Cell)
  • +2 more
  • trientine dihydrochloride
  • +2 more
  • (no location specified)
Oct 18, 2020

Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)

Not yet recruiting
  • Head and Neck Cancer
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Oct 24, 2023

COVID-19 Trial in Kermanshah (Deferoxamine)

Unknown status
  • COVID-19
  • Kermanshah, Iran, Islamic Republic of
    Regenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020

Thalassemia Major Trial (n-acetylcystine)

Not yet recruiting
  • Thalassemia Major
  • (no location specified)
Mar 9, 2023

Prostate Cancer Trial in Beijing (2.0 GBq of 177Lu-EB-PSMA)

Recruiting
  • Prostate Cancer
  • 2.0 GBq of 177Lu-EB-PSMA
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 13, 2022

Metastatic Prostate Cancer Trial in Perth (64Cu-DOTA-TLX592)

Recruiting
  • Metastatic Prostate Cancer
  • Perth, Western Australia, Australia
  • +1 more
Nov 25, 2022

Assess Iron Chelation Therapy in Chronic Iron Overload

Completed
  • Chronic Iron Overload
  • Iron chelator
  • Winnenden, Baden Wuerttemberg, Germany
  • +102 more
Jun 29, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11GBq of 177Lu-EB-PSMA-617
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 6, 2022

Pulmonary Fibrosis Trial in Beijing (99mTc-HFAPI)

Recruiting
  • Pulmonary Fibrosis
  • Beijing, Dongcheng, China
    Peking union medical college hospital
May 5, 2023

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)

No longer available
  • Pantothenate Kinase-Associated Neurodegeneration
  • (no location specified)
Nov 9, 2022

Mercury Poisoning Trial in Barranquilla ((N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose,

Not yet recruiting
  • Mercury Poisoning
  • (N1, N3-bis(2- mercaptoethyl)isophthalamide)
  • Excipients microcrystalline cellulose, silica and magnesium stearate
  • Barranquilla, Atlántico, Colombia
    Clínica de la Costa Ltda.
Nov 29, 2022

Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-TLX591)

Not yet recruiting
  • Metastatic Prostate Cancer
  • 177Lu-DOTA-TLX591
  • Perth, Western Australia, Australia
  • +1 more
Nov 25, 2021

Ischemic Stroke, Acute Trial in Spain (Deferoxamine)

Completed
  • Ischemic Stroke, Acute
  • Badalona, Barcelona, Spain
  • +3 more
Aug 4, 2022

Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)

Not yet recruiting
  • Prostate Cancer
  • 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
  • PET MRI Imaging
  • New York, New York
    Smilow Comprehensive Prostate Cancer Center
Jan 9, 2023

Different Risk Factors on Growth Parameters of Thalassemic

Not yet recruiting
  • Thalassemia Major
  • serum ferritin and AST
  • (no location specified)
Mar 29, 2022

Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)

Not yet recruiting
  • Prostate Cancer
  • 177Lu-DOTA-TLX591
  • St Leonards, New South Wales, Australia
  • +1 more
Jul 18, 2022

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
Jan 31, 2022

Glioma Trial in Beijing (68Ga-P16-093)

Recruiting
  • Glioma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 4, 2022